Dr. Vijay Chidrawar

Assistant Professor
Specialization: Pharmacology
Qualification: M. Pharm, Ph.D.

Research Profiles -

Google Scholar:  https://scholar.google.com/citations?user=Wj5WQu0AAAAJ&hl=en

 ResearchGate:   https://www.researchgate.net/profile/Vijay-Chidrawar

Scopus: https://www.scopus.com/authid/detail.uri?authorId=36112997500

Research interests

Cancer metastasis, ion-channels, angiogenesis, Bone disorders, Drug repurposing, infertility, metabolic syndrome

Teaching interest

Pharmacology, Clinical Toxicology, Pathophysiology, Clinical Pharmacy, Pharmacotherapeutics, Scientific Medical writing 

Work Experience: 18 Years (16 years in Academic and 2 years in industry)

• 10.6 years – Post PhD
• 6 years - Post PG
• 2 Years - Post Graduation

AWARDS AND HONORS

• Best poster presentation award at DUPHAT International Conference, Dubai, UAE. 2016
• Universal Out Standing Researcher Award (2020)- International American Council for Research and Development - USA
• National Eminent Young Scientist Award 2020 by I2OR (International Institute of Organized Research) India.
• Top 50 International Distinguished Young Scientist Award 2020 by Green Thinkersz. India.

Research Grants Completed: 8

• Principal Investigator: 5
• Co-investigator: 3

1. "Pre-Clinical Experimental Study To Investigate The Role Of Calcium Channel Modulators In Obesity” March 2019. Project Grant Number:  8031-PHM-2018-3-9-F. Principal Investigator. (Completed)
2.  "Spectrum and Extent of Multidrug resistance among gram negative E. coli in fresh meat and chicken in Rafha, Saudi Arabia” in March 2019. Co-Investigator. (Completed)
3. "Compare and Define the Role of Ion-Conductors in Gastrointestinal Inflammation” March 2019. Project Grant Number: 7895-PHM-2018-3-9-F. Principal Investigator. (Completed)
4. "Pharmacological evaluation of antiepileptic activity of Comminphora myrrha in experimental animals” March 2019. Project Grant Number: PHM-2019-1-10-F 8387. Co-Investigator. (Completed)
5. "Comparative Experimental Studies of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiogenesis Against Various Models of Angiogenesis” Sep 2017, Project Grant Number: 7167-PHM-2017-1-7-F. Principal Investigator. (Completed)
6. "A Study to investigate the role of voltage dependent Calcium channel blockers (Cav) in Angiogenesis” Sep 2016, Project Grant Number: 5777-PHM-2016-1-6-F. Principal Investigator. (Completed)
7. "A study to explore the role of ion- Channels in bone remolding process and Osteoporosis” Sep 2015, Project Grant Number: 1/6/1436/5. Principal Investigator. (Completed)

8. "Immunomodulating, Anti-Bacterial and Anti-Cancer Potential of Za’atar (Thymus Vulgaris) and Its Combination With Essential Oil (Olive And Balsam Oil)”. Co-Investigator. (Completed)

Professional Memberships:

• Life member of Indian Pharmacological Society, LC 102.
• Life-member of Indian Pharmacognosy Society, ISP/LM-MS/C-035.
• Life member of Indian Pharmacy Graduate’ Association, LM-7714
• Recognized PhD guide - Manipal University
• Recognized PhD guide - Jawaharlal Nehru Technological University Anantapur.
• Recognized as CCSEA Nominee
• Registered Pharmacist, Maharashtra State Pharmacy Council, Mumbai. No.71731.

Recent Publications:

1. Chidrawar, V.R., Singh, S., Jayeoye, T.J. et al.Porous Swellable Hypromellose Composite Fortified with Eucalyptus camaldulensis Leaf Hydrophobic/Hydrophilic Phenolic-rich Extract to Mitigate Dermal Wound Infections. J Polym Environ (2023). https://doi.org/10.1007/s10924-023-02860-8. (Springer Nature, IF: 4.705)
2. Alotaibi, Ghallab, Sitah Alharthi, Biswajit Basu, Dipanjana Ash, Swarnali Dutta, Sudarshan Singh, Bhupendra G. Prajapati, Sankha Bhattacharya, Vijay R. Chidrawar, and Havagiray Chitme. 2023. "Nano-Gels: Recent Advancement in Fabrication Methods for Mitigation of Skin Cancer" Gels9, no. 4: 331. https://doi.org/10.3390/gels9040331. (MDPI, IF: 4.432)
3. Singh, S., Chidrawar, V.R., Hermawan, D. et al.Hypromellose Highly Swellable Composite Fortified with Psidium Guajava Leaf Phenolic-rich Extract for Antioxidative, Antibacterial, Anti-inflammatory, Anti-melanogenesis, and Hemostasis Applications. J Polym Environ (2023). https://doi.org/10.1007/s10924-023-02819-9. (Springer Nature, IF: 4.705)
4. Pachauri, Ankur, Havagiray Chitme, Sharad Visht, Vijay Chidrawar, Nawaj Mohammed, Basel A. Abdel-Wahab, Masood Medleri Khateeb, Mohammed Shafiuddin Habeeb, Mohamed A. A. Orabi, and Marwa B. Bakir. 2023. "Permeability-Enhanced Liposomal Emulgel Formulation of 5-Fluorouracil for the Treatment of Skin Cancer" Gels9, no. 3: 209. https://doi.org/10.3390/gels9030209 (MDPI, IF: 432)
5. Shiromwar SS, Khan AH, Chidrawar V. A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes. Rev Esp Quimioter. 2023 Feb;36(1):30-44. doi: 10.37201/req/029.2022. Epub 2022 Dec 9. PMID: 36503203; PMCID: PMC9910680. (Sociedad Española, IF: 2.5)
6. Chidrawar V, Alsuwayt B. Defining the role of CFTR channel blocker and ClC-2 activator in DNBS induced gastrointestinal inflammation. Saudi Pharm J. 2021 Apr;29(4):291-304. doi: 10.1016/j.jsps.2021.02.005. Epub 2021 Mar 10. PMID: 33994824; PMCID: PMC8093574. (Elsevier IF: 4.562)